Search

everythinglearnresearchcommunity

for

Search:↓

A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

AI can predict hair loss patterns to improve care and treatment.

Women with female pattern hair loss may have a higher risk of metabolic syndrome.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Adult tissue stem cells can adapt and switch roles to help repair and maintain the body.

Personalized acne treatments and new therapies show promise for better results.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Acne can't be cured but can be managed with treatments like benzoyl peroxide and diet changes; it's costly and can lead to scarring and mental health issues.

Natural antioxidants like flavonoids and resveratrol may help prevent low testosterone in aging men.

Hormone levels in hair change during pregnancy, with progesterone increasing significantly compared to non-pregnant women.

Female pattern hair loss has multiple causes and treatments, with new therapies showing promise.

The statement offers guidance for hormone therapy and surgery to help gender-incongruent adults affirm a male identity.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

The 2003 Australian Medicines Handbook was a clear, concise drug reference guide, updated with new topics and evidence, and considered essential for medical practice.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Hair loss peaks in spring and regrowth in late summer, with pregnant females losing the most hair.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

The document concludes that more inclusive research involving the transgender community is needed, especially on the neovaginal microbiome of trans women.

Hair color is determined by melanin produced and transferred in hair follicles.

Human skin can produce steroids from cholesterol.

Two rare genetic diseases cause severe rickets in children due to defects in vitamin D metabolism.

Long-term use of azole antifungals can cause hair loss, hormonal imbalances, and severe skin reactions.

Insulin resistance might not be enough to worsen blood vessel function in young, nonobese women with polycystic ovary syndrome.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

Inflammation may play a role in causing androgenetic alopecia.

Preventing and managing skin issues from cancer treatment is crucial, especially in high UV areas like Australia and New Zealand.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.